Institute on Alcohol Abuse and Alcoholism guidelines and/or any
tobacco use should receive a brief motivational counseling
intervention by a healthcare worker trained in this technique.
Promoting Engagement in Treatment for Substance Use Illness
5. Healthcare providers should systematically promote patient initiation
of care and engagement in ongoing treatment for substance use illness.
Patients with substance use illness should receive supportive services
to facilitate their participation in ongoing treatment.
Withdrawal Management
6. Supportive pharmacotherapy should be available and provided to manage
the symptoms and adverse consequences of withdrawal, based on a
systematic assessment of the symptoms and risk of serious adverse
consequences related to the withdrawal process. Withdrawal management
alone does not constitute treatment for dependence and should be
linked with ongoing treatment for substance use illness.
Therapeutic Interventions to Treat Substance Use Illness
Psychosocial Interventions
7. Empirically validated psychosocial treatment interventions should be
initiated for all patients with substance use illnesses.
Pharmacotherapy
8. Pharmacotherapy should be recommended and available to all adult
patients diagnosed with opioid dependence and without medical
contraindications. Pharmacotherapy, if prescribed, should be provided
in addition to and directly linked with psychosocial
treatment/support.
9. Pharmacotherapy should be offered and available to all adult patients
diagnosed with alcohol dependence and without medical
contraindications. Pharmacotherapy, if prescribed, should be provided
in addition to and directly linked with psychosocial
treatment/support.
10. Pharmacothe
'/>"/>
| SOURCE National Quality Forum Copyright©2007 PR Newswire. All rights reserved |